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Abstract. 
 
While the Vpr protein of HIV-1 has been im-
plicated in import of the viral preintegration complex 
across the nuclear pore complex (NPC) of nondividing 
cellular hosts, the mechanism by which Vpr enters the 
nucleus remains unknown. We now demonstrate that 
Vpr contains two discrete nuclear targeting signals that 
use two different import pathways, both of which are 
distinct from the classical nuclear localization signal 
(NLS)- and the M9-dependent pathways. Vpr import 
does not appear to require Ran-mediated GTP hydrol-
ysis and persists under conditions of low energy. Com-
petition experiments further suggest that Vpr directly 
engages the NPC at two discrete sites. These sites ap-
pear to form distal components of a common import 
pathway used by NLS- and M9-containing proteins. To-
gether, our data suggest that Vpr bypasses many of the 
soluble receptors involved in import of cellular cargoes. 
Rather, this viral protein appears to directly access the 
NPC, a property that may help to ensure the capacity of 
HIV to replicate in nondividing cellular hosts.
Key words: Vpr ¥ nuclear import ¥ HIV ¥ nuclear 
pore complex ¥ preintegration complex
A
 
crucial event in the early stages of the human immu-
 
nodeficiency virus (HIV)
 
1
 
 life cycle in nondividing
cells is the active transport of the viral preintegra-
tion complex (PIC) across the nuclear envelope, thereby
permitting integration of HIV DNA into the host chromo-
some. The ability of HIV to infect such nondividing cells
as terminally differentiated macrophages distinguishes this
and the other primate lentiviruses from the oncoretrovi-
ruses that only infect proliferating cells (Humphries and
Temin, 1974). For example, nuclear entry and integration
of murine leukemia virus DNA requires passage of the
host cell through mitosis, at which time the nuclear mem-
brane breaks down and the virus gains entry into the nu-
cleus (Roe et al., 1993; Lewis and Emerman, 1994). In the
case of HIV, the matrix (Bukrinsky et al., 1993; von Schwed-
ler et al., 1994; Gallay et al., 1995), integrase (Gallay et al.,
1997), and Vpr (Heinzinger et al., 1994; Popov et al., 1998;
Vodicka et al., 1998) proteins have all been identified as
possible mediators of viral PIC nuclear localization. The
matrix and integrase proteins contain classical SV-40—like
nuclear localization signal (NLS) sequences and appear to
use importin 
 
a
 
/importin 
 
b
 
 (see below) for transport across
the nuclear pore complex (NPC) (Bukrinsky et al., 1993;
Gallay et al., 1996, 1997; Popov et al., 1996). However, the
precise contribution of matrix and integrase to PIC import
remains unclear (Freed et al., 1995; Fouchier et al., 1997).
While Vpr is believed to contribute to nuclear targeting of
the viral PIC, nuclear import of Vpr is a poorly understood
process. The signal within Vpr responsible for nuclear lo-
calization is not known, and the import pathway used by
Vpr is also not defined. Vpr significantly enhances viral
replication in terminally differentiated macrophages (Con-
nor et al., 1995), a function believed to be related to its
karyophilic properties (Heinzinger et al., 1994).
Vpr is a small protein that is composed of only 96 amino
acids and is efficiently packaged into virions (Cohen et al.,
1990; Yuan et al., 1990) because of its association with the
 
p6 region of the p55
 
gag
 
 precursor (Paxton et al., 1993; Lu
et al., 1995). In addition to its enhancement of replication
in nondividing macrophages, Vpr also causes proliferating
human cells to undergo an arrest or delay in the G2 phase
of the cell cycle (He et al., 1995; Jowett et al., 1995; Re et al.,
1995; Emerman, 1996). This property of Vpr may serve to
amplify viral gene expression since the HIV-1 long termi-
nal repeat is more active during G2 (Goh et al., 1998).
Secondary structure analysis of Vpr predicts the pres-
ence of two 
 
a
 
-helical domains within the NH
 
2
 
-terminal 70
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1. 
 
Abbreviations used in this paper:
 
 
 
b
 
gal, 
 
b
 
galactosidase; GST, glu-
tathione-S-transferase; HIV, human immunodeficiency virus; IBB, impor-
tin 
 
b
 
 binding domain; NLS, nuclear localization signal; NPC, nuclear pore
complex; PIC, preintegration complex; WGA, wheat germ agglutinin.
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amino acids (Mahalingam et al., 1995). Vpr binding to
p6
 
gag
 
 and virion incorporation appear to require the first of
these two 
 
a
 
-helical domains. In contrast, many of the de-
terminants of cell cycle arrest reside in the arginine-rich
COOH-terminal portion of the protein (Di Marzio et al.,
1995; Zhou et al., 1998). This COOH-terminal region of
Vpr most closely resembles a canonical NLS; however,
this region can be deleted with no impairment of nuclear
localization (Di Marzio et al., 1995). Nevertheless, a recent
study indicates that substitution of five arginines located
within the COOH-terminal region with glutamine residues
leads to a cytoplasmic pattern of Vpr localization, suggest-
ing that the COOH-terminal region participates in nuclear
targeting (Zhou et al., 1998). The NH
 
2
 
-terminal portion of
Vpr does not bear any resemblance to a canonical NLS;
amino acid mutations scattered throughout this region dis-
rupt the nuclear targeting function of Vpr (Mahalingam
et al., 1997). Furthermore, mutational analysis suggests the
importance of the predicted 
 
a
 
-helical secondary structure
for nuclear localization of Vpr (Di Marzio et al., 1995; Ma-
halingam et al., 1995).
The previously characterized pathways for signal-medi-
ated import of proteins into the nucleus share several fea-
tures. First, the signal-bearing karyophilic protein is recog-
nized by a specific transport receptor, and secondly, the
protein complex is actively translocated through the NPC.
Finally, once in the nucleus, the transported cargo dissoci-
ates from the receptor, and the receptor is recycled to the
cytoplasm (Nigg, 1997; Ohno et al., 1998). The best-char-
acterized nuclear import pathway is for proteins contain-
ing a basic residue—rich NLS, the prototype being the NLS
present in the large T antigen of SV-40. Proteins contain-
ing such a classical, positively charged NLS bind to a het-
erodimeric receptor complex composed of importin 
 
a
 
(karyopherin 
 
a
 
; for alternate names see Nigg, 1997) (Gr-
lich et al., 1994; Weis et al., 1995) and importin 
 
b
 
 (karyo-
pherin 
 
b
 
, p97) (Chi et al., 1995; Grlich et al., 1995
 
a
 
; Radu
et al., 1995
 
a
 
). Importin 
 
a
 
 is responsible for binding to the
NLS-bearing protein, while importin 
 
b
 
 mediates binding
of the transport complex to the NPC (Grlich et al.,
1995
 
b
 
). The interaction of importin 
 
a
 
 with importin 
 
b
 
 oc-
curs through the NH
 
2
 
 terminus of importin 
 
a
 
 termed the
importin 
 
b
 
 binding domain (IBB). When fused to heterol-
ogous proteins, the IBB domain alone is sufficient to pro-
duce nuclear entry via importin 
 
b
 
 (Grlich et al., 1996
 
a
 
;
Weis et al., 1996). The importin 
 
a
 
/importin 
 
b
 
 system also
requires the participation of the small Ras-related GTP-
ase, Ran/TC4 (Moore and Blobel, 1993; Melchior et al.,
1993), and p10 (NTF2) (Moore and Blobel, 1994; Paschal
and Gerace, 1995). However, the mechanism of cargo
translocation and the exact contribution of Ran-mediated
GTP hydrolysis to the import reaction are not well under-
stood. The asymmetric distribution of the GTPase activat-
ing protein, RanGAP (cytoplasm), and the nucleotide ex-
change factor, RCC1 (nucleus), is predicted to generate a
steep gradient of RanGTP between these two cellular
compartments, and this gradient may confer vectoriality to
the various transport pathways (Grlich et al., 1996
 
b
 
; Izaur-
ralde et al., 1997
 
a
 
). In this regard, once the importin 
 
a
 
/im-
portin 
 
b
 
/cargo complex reaches the nucleus, RanGTP
binding to importin 
 
b
 
 dissociates the ternary complex, al-
lowing cargo delivery and recycling of importin 
 
a
 
 and im-
portin 
 
b
 
 to the cytoplasm (Rexach and Blobel, 1995; Gr-
lich et al., 1996
 
b
 
; Koepp and Silver, 1996).
A distinct nuclear import pathway has been identified
for the RNA binding protein hnRNP A1. This protein
contains a signal sequence termed M9 that bears no se-
quence homology to the classical NLS and mediates both
nuclear import and export of hnRNP A1 (Siomi and Drey-
fuss, 1995; Michael et al., 1995). Transportin, a novel re-
ceptor distantly related to importin 
 
b
 
, binds to the M9 do-
main and mediates the import of hnRNP A1 in vitro
(Aitchison et al., 1996; Pollard et al., 1996; Fridell et al.,
1997). As in the classical NLS pathway, import of hnRNP
A1 is dependent on the presence of Ran/TC4 (Nakielny et
al., 1996). Binding of RanGTP to transportin in the nu-
cleus also leads to the dissociation of hnRNP A1 and recy-
cling of transportin to the cytoplasm (Izaurralde et al.,
1997
 
b
 
; Siomi et al., 1997).
Importin 
 
b
 
 and transportin are members of a large su-
perfamily of proteins that contain RanGTP binding do-
mains and are believed to function as nuclear transport re-
ceptors for unknown cellular cargoes (Fornerod et al.,
1997
 
a
 
; Grlich et al., 1997). More recently, members of
this superfamily have been implicated in the import of ri-
bosomal proteins (Rout et al., 1997; Schlenstedt et al.,
1997), the import of proteins involved in RNA processing
(Pemberton et al., 1998; Rosenblum et al., 1998; Senger et
al., 1998), as well as the export of importin 
 
a
 
 (Kutay et al.,
1997
 
a
 
), the export of tRNA (Arts et al., 1998; Kutay et al.,
1998), and cytoplasmic delivery of proteins containing a
leucine-rich nuclear export signal like that found in HIV
Rev (Fornerod et al., 1997b; Fukuda et al., 1997; Ossareh-
Nazari et al., 1997; Stade et al., 1997).
Using an established in vitro nuclear import assay, we
now demonstrate that HIV Vpr contains two distinct nu-
clear targeting signals that use different receptors for entry
into the nucleus. Furthermore, we show that neither of
these Vpr signals is dependent on importin 
 
a
 
/importin 
 
b
 
or transportin for nuclear entry and that Ran/TC4-medi-
ated GTP hydrolysis does not appear to be required. We
further find that both signals in Vpr operate efficiently un-
der conditions of minimal energy. Finally, competition ex-
periments suggest that Vpr directly engages the NPC at
two discrete sites in a pathway of nuclear import also used
by NLS- and M9-containing proteins. Our data support an
entry mechanism in which Vpr bypasses the soluble recep-
tors involved in import of cellular cargoes and, instead, di-
rectly targets factors located within the NPC itself.
 
Materials and Methods
 
Plasmid Construction and Expression and Purification 
of Recombinant Proteins
 
The plasmid encoding the 
 
b
 
galactosidase (
 
b
 
gal) fusion protein was con-
structed by inserting a PCR fragment corresponding to the 
 
lacZ
 
 sequence
of 
 
Escherichia coli
 
 into the XbaI/XmaI restriction sites in the pCMV4 eu-
karyotic expression vector. The 5
 
9 
 
PCR primer incorporated a thrombin
cleavage site (Leu-Val-Pro-Arg-Gly-Ser) located between the XbaI site
and the first codon of 
 
lacZ
 
. Full-length Vpr and the Vpr deletion mutants
were constructed by inserting the appropriate PCR fragments into the
HindIII/XbaI sites of pCMV-3
 
9 b
 
gal. All Vpr sequences were derived
from the NL4-3 allele of HIV-1. Expression of recombinant fusion pro-
teins in 
 
E
 
.
 
 coli
 
 was performed using the pET28 vector (Novagen, Madi-
son, WI). All Vpr constructs were confirmed by DNA sequencing, and
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protein expression was confirmed by immunoblotting with an anti-
 
b
 
gal
monoclonal antibody (Boehringer Mannheim Corp., Indianapolis, IN).
The plasmid encoding glutathione-S-transferase (GST)-M9 was prepared
by inserting the M9 sequence (amino acids 268—305 of hnRNP A1) ampli-
fied from EST clone 81773 into the EcoRI/XhoI sites in pGEX-4T1 (Phar-
macia Biotech, Piscataway, NJ). The prokaryotic expression vector for im-
portin 
 
b
 
 (71—876) was a gift from Dr. S. Adam (Northwestern University,
Chicago, IL).
Recombinant fusion proteins were expressed in 
 
E
 
. 
 
coli
 
 strain
BL21(DE3). Cultures were grown to an OD
 
600 nm 
 
of 0.9 and induced with
1 mM IPTG for 2—5 h at 30
 
8
 
C. After washing with PBS, bacterial pellets
were resuspended in 20 mM Hepes, pH 7.3, 100 mM NaCl, 1 mM 
 
b
 
ME,
and 10% glycerol (buffer A) and sonicated. Fusion proteins containing
Vpr or Vpr fragments consistently partitioned into the insoluble fraction
when prepared by this method. Inclusion bodies were solubilized by soni-
cation in 5 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl, pH 7.9, and 6 M
urea (buffer B) and incubated overnight at 0
 
8
 
C. After ultracentrifugation
of lysates, soluble fusion proteins were isolated using Ni-NTA chromatog-
raphy (Invitrogen Corp., Carlsbad, CA). Proteins were eluted from resin
using buffer B containing 4 M imidazole. The denatured proteins were re-
folded by slow dialysis into buffer A. After completion of the experiments
included in this manuscript, Vpr(73—96)—
 
b
 
gal was subsequently produced
in a soluble form. Partial characterization in vitro
 
 
 
of soluble FITC-labeled
Vpr(73—96)—
 
b
 
gal showed no apparent differences from the denatured/
renatured form of the protein. IBB—
 
b
 
gal, importin 
 
b
 
 (71—876), RanQ69L,
and GST-M9 were produced as previously described (Bischoff et al., 1994;
Pollard et al., 1996; Weis et al., 1996; Chi et al., 1997). Peptides encoding
Vpr(73—96) or the same sequence in reverse order as a control were ob-
tained from Research Genetics (Huntsville, AL). Purity of peptides was
confirmed by mass spectrometry and HPLC analysis. Fluorescent labeling
of proteins was performed as detailed in the instructions included with the
 
N
 
-hydroxylsuccinimide esters of either rhodamine isothiocyanate or fluo-
rescein (Pierce Chemical Co., Rockford, IL). Excess label was removed by
dialysis into buffer A.
 
Indirect Immunofluorescence
 
Before transfection, HeLa cells (American Type Culture Collection,
Rockville, MD) were plated onto glass coverslips. Transfections were per-
formed using calcium phosphate precipitates. After 48 h, cells were
stained as described previously (Weis et al., 1996). The primary antibody
was an anti-
 
b
 
gal monoclonal antibody used at a dilution of 1:500 in 10%
BSA in PBST (0.05% Tween-20 in PBS). FITC- or LRSC-conjugated sec-
ondary anti—mouse antibodies (Jackson ImmunoResearch, West Grove,
PA) were used at a dilution of 1:100 in 10% BSA in PBST. Coverslips
were mounted using Gel Mount (Biomeda Corp., Foster City, CA), and
samples were imaged using a scanning confocal microscope (model MRC-
600; Bio-Rad Labs, Hercules, CA).
 
In Vitro Nuclear Transport Assay
 
HeLa cells were plated onto glass coverslips 24 h before treatment for 5
min at room temperature with 50 
 
m
 
g/ml digitonin (Fluka AG, Buchs, Swit-
zerland) in transport buffer (20 mM Hepes, KOH, pH 7.3, 110 mM potas-
sium acetate, 5 mM sodium acetate, 2 mM magnesium acetate, 1 mM
EGTA, and 2 mM DTT) (Adam et al., 1990). Import reactions were
mixed in a volume of 10 
 
m
 
l, spun at 10,000 rpm for 15 min at 4
 
8
 
C, and then
overlaid on top of the coverslips containing the plated HeLa cells. Rabbit
reticulocyte lysate containing an energy-regenerating system (Promega
Corp., Madison, WI) was used as a source of cytosolic factors. Transport
reactions were always performed in parallel with IBB—
 
b
 
gal as a control.
Vpr fusion proteins and GST-M9 were used at a concentration of 20 ng/
 
m
 
l,
while IBB—
 
b
 
gal was used at 40 ng/
 
m
 
l. Protein concentrations were dou-
bled for competition reactions using the Vpr peptides. Transport reactions
were set up on ice and then allowed to proceed at room temperature for
1 h. Coverslips were washed with PBST, fixed, mounted, and then imaged
as described above.
 
Results
 
Nuclear Localization of Vpr Is a
Signal-mediated Process
 
Vpr has been previously shown to localize to the nucleus,
 
both in transiently transfected cells and in cells infected
with HIV (Lu et al., 1993; Zhao et al., 1994; Yao et al.,
1995). Since the molecular mass of Vpr (14 kD) is substan-
tially smaller than the 40—60-kD size limit for passive dif-
fusion of proteins through the NPC, the observed nuclear
location of Vpr could result from at least two possible
mechanisms: (
 
a
 
) Vpr is imported via a nuclear targeting
signal, or (
 
b
 
) Vpr enters the nucleus by passive diffusion
and is retained in that cellular compartment by binding to
nuclear proteins. To distinguish between these two possi-
bilities, we constructed a chimeric protein consisting of
Vpr fused at its COOH terminus to 
 
b
 
gal, and analyzed its
subcellular localization both in vivo after transfection in
HeLa cells and in vitro using digitonin-permeabilized
HeLa cells and fluorescently labeled recombinant Vpr—
 
b
 
gal
fusion proteins (Fig. 1). The size of the resulting fusion
protein (
 
z
 
130 kD for the monomer and 
 
z
 
520 kD for the
tetramer) is sufficiently large to preclude passive diffusion
into the nucleus.
As expected, in transiently transfected HeLa cells, 
 
b
 
gal
alone localized to the cytoplasm (Fig. 1 
 
A
 
). In contrast, the
Vpr—
 
b
 
gal fusion protein was almost exclusively localized
to the nucleus (Fig. 1 
 
B
 
) of the transfected cells. Using in-
direct immunofluorescence, we observed nucleoplasmic
but nonnucleolar staining of more than 85% of the trans-
fected cells. These subcellular localization results were ad-
ditionally confirmed in biochemical fractionation studies
where Vpr—
 
b
 
gal was principally detected in the nuclear
fraction while 
 
b
 
gal alone was cytoplasmic (data not
shown). From these experiments, we conclude that Vpr
contains a nuclear targeting signal that mediates nuclear
uptake.
Figure 1. Nuclear import of Vpr is a signal-mediated process. In-
direct immunofluorescence of HeLa cells transfected with an ex-
pression plasmid encoding either bgal (A) or Vpr—bgal fusion
protein (B). Import of FITC-labeled bgal (C), IBB—bgal (D), and
Vpr—bgal (E) in digitonin-permeabilized cells. Reactions shown
here and in all of the following figures contain rabbit reticulocyte
lysate with an energy-regenerating system unless otherwise indi-
cated.
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We next evaluated whether Vpr-mediated nuclear im-
port could be reconstituted in vitro using digitonin-perme-
abilized HeLa cells. As a positive control, we used a chi-
meric protein consisting of 
 
b
 
gal fused to the IBB domain
of importin 
 
a
 
. The IBB—
 
b
 
gal protein, as previously re-
ported (Grlich et al., 1996
 
a
 
; Weis et al., 1996), was effi-
ciently localized to the nucleus (Fig. 1 D), while bgal alone
was cytoplasmic (Fig. 1 C). Consistent with the in vivo ob-
servations, fusion of the bgal reporter protein to Vpr ef-
fectively redirected this normally cytoplasmic protein to
the nucleus (Fig. 1 E). While localized to the nucleoplasm,
the Vpr—bgal protein was excluded from the nucleoli.
To investigate whether Vpr—bgal nuclear uptake re-
flected active transport across the nuclear pore, the effects
of wheat germ agglutinin (WGA) were examined. This
lectin binds to N-acetyl-d-glucosamine residues present on
many of the nucleoporins and blocks NLS-mediated im-
port without restricting passive diffusion of small mole-
cules (Finlay et al., 1987). Addition of WGA markedly in-
hibited nuclear uptake of both IBB—bgal (Fig. 2 B) and
Vpr—bgal (Fig. 2 F). Vpr-mediated nuclear import was
also examined in the presence of a dominant-negative im-
portin b deletion mutant, importin b (71—876). This mu-
tant lacks a RanGTP binding domain and has been shown
to inhibit multiple pathways of nuclear import and export
across the NPC (Izaurralde et al., 1997a; Kutay et al.,
1997b). Addition of importin b (71—876) effectively
blocked nuclear localization of both IBB—bgal (Fig. 2 C)
and Vpr—bgal (Fig. 2 G). Finally, we examined the temper-
ature dependence of the Vpr-mediated import reaction.
When the import reaction was performed on ice (08C) in-
stead of at room temperature (258C), nuclear localization
of both IBB—bgal (Fig. 2 D) and Vpr—bgal was inhibited
(Fig. 2 H). Taken together, these results indicate that nu-
clear import of Vpr is a temperature-dependent, signal-medi-
ated process that proceeds through the NPC.
Vpr Contains Two Independent Nuclear
Targeting Signals with Receptor Requirements Distinct 
from NLS- and M9-mediated Import
We next investigated what sequences within Vpr are both
necessary and sufficient for the observed nuclear uptake
of Vpr—bgal. As a first step, two Vpr fragments containing
amino acids 1—71 and 73—96 were individually fused to
bgal and tested. Unexpectedly, both of these Vpr frag-
ments effectively targeted the bgal protein to the nucleus
in vivo (Fig. 3, A and B) and in vitro (Fig. 3, C and D).
These findings suggest that Vpr contains at least two func-
tional nuclear targeting signals.
A prior study had indicated that saturation of the classi-
cal NLS pathway using a peptide corresponding to the SV-
40 large T antigen sequence had no inhibitory effect on
Vpr import (Gallay et al., 1996). This result suggests that
Vpr does not bind to importin a at the NLS cargo site but
does not exclude direct binding to importin b. In this re-
Figure 2. Comparison of
NLS-mediated (A—D) and
Vpr-mediated (E—H) nuclear
import in vitro. Import of
IBB—bgal as a probe of the
NLS pathway or Vpr—bgal
was performed in the pres-
ence of lysate alone (A and
E), lysate supplemented
with WGA (50 mg/ml) (B
and F), or lysate containing 8
mM importin b (71—876) (C
and G). Import reactions
containing IBB—bgal (D) or
Vpr—bgal (H) fusion proteins
were also performed at 08C
instead of 258C.
Figure 3. Vpr contains two independent nuclear targeting signals.
(A and B) Subcellular localization was determined for Vpr
(1—71)—bgal and Vpr(73—96)—bgal in transiently transfected
HeLa cells. Fusion proteins were detected by indirect immuno-
fluorescence using antibodies specific for bgal. (C and D) Import
of Vpr(1—71)—bgal and Vpr(73—96)—bgal fusion proteins was also
analyzed in vitro in the digitonin-permeabilized HeLa cell system.
Jenkins et al. Characterization of HIV-1 Vpr Nuclear Import 879
gard, importin b—dependent and importin a—independent
nuclear entry has been reported for translocation of U sn-
RNPs (Palacios et al., 1997). To further confirm the lack of
importin a involvement and to probe the use of importin b
by Vpr, we performed nuclear import assays in the pres-
ence of excess IBB as an unlabeled competitor. Inclusion
of the IBB domain potently inhibited NLS-mediated im-
port in vitro (Fig. 4, A vs. B) by saturating the importin a
binding site on importin b (Grlich et al., 1996; Weis et al.,
1996). In contrast, the addition of the IBB competitor did
not impair nuclear uptake of Vpr—bgal (Fig. 4, C vs. D).
However, since one but not both of the Vpr signals might
involve the NLS pathway, each signal was individually
tested. The addition of the IBB competitor did not inhibit
either Vpr signal (Vpr[1—71], Fig. 4, E vs. F, or Vpr[73—96],
Fig. 4, G vs. H). Together, these findings indicate that Vpr
does not use the classical NLS pathway for nuclear entry
via either of its nuclear targeting signals.
After the classical NLS pathway, the best-characterized
import process is the M9 pathway used by the hnRNP A1
protein and its receptor transportin. To probe VprÕs use of
the M9 pathway, competition experiments using the M9
nuclear targeting sequence were performed. As expected,
saturation of the M9 pathway using an excess of the M9
signal sequence inhibited nuclear import of fluorescently
labeled GST-M9 (Fig. 4, I vs. J). However, addition of ex-
cess GST-M9 had no effect on protein import mediated by
full-length Vpr (Fig. 4, K vs. L), Vpr(1—71) (Fig. 4, M vs.
N), or Vpr(73—96) (Fig. 4, O vs. P). Consistent with previ-
ously reported data (Izaurralde et al., 1997b), addition of
the M9 competitor also had no inhibitory effect on nuclear
import of IBB—bgal (data not shown). Thus, Vpr nuclear
entry does not appear to involve the transportin-depen-
dent M9 pathway.
Vpr Nuclear Import Does Not Require GTP Hydrolysis 
by Ran/TC4
To further characterize the transport pathway(s) used by
the two signals of Vpr, the requirement for GTP hydroly-
sis by Ran/TC4 was studied using a dominant-negative
mutant of Ran, RanQ69L. This mutant binds GTP but is
unable to hydrolyze this nucleotide triphosphate and con-
sequently remains in the GTP-bound state. Addition of
RanQ69L has been shown to block nuclear import of
NLS- (Palacios et al., 1996) and M9-containing proteins
(Nakielny et al., 1996) as well as nuclear import of U sn-
RNPs (Palacios et al., 1996). Consistent with these results,
inclusion of the RanQ69L mutant blocked IBB—bgal im-
port (Fig. 5, A vs. B). In contrast, the RanQ69L mutant
displayed no inhibitory effects on nuclear import mediated
by either Vpr(1—71)—bgal (Fig. 5, C vs. D), Vpr(73—96)—
bgal (Fig. 5, E vs. F), or full-length Vpr—bgal (Fig. 5, G vs.
H). These results suggest that nuclear import mediated by
either Vpr signal proceeds independently of Ran-medi-
ated GTP hydrolysis.
Figure 4. Vpr does not use
the classical NLS or the M9
pathway for entry into the nu-
cleus. (A—H) Import of IBB—
bgal, Vpr—bgal, Vpr(1—71)—
bgal, and Vpr(73—96)—bgal
with lysate (control) (A, C, E,
and G) or with lysate contain-
ing 30 mM unlabeled IBB as a
competitor (B, D, F, and H).
(I—P) Import of GST-M9
(FITC-labeled), Vpr—bgal,
Vpr(1—71)—bgal, and Vpr(73—
96)—bgal with lysate (control)
(I, K, M, and O) or with lysate
containing 15 mM unlabeled
GST-M9 (J, L, N, and P). In-
hibition of the nuclear import
reaction may be manifested
by a cytoplasmic pattern of
staining (B) or a general de-
crease in the fluorescence in-
tensity reflecting exit from the
permeabilized cell (J).
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The Two Nuclear Targeting Signals of Vpr Exhibit 
Similar Properties
To further compare the two targeting signals within Vpr,
we examined nuclear import of the Vpr(1—71)—bgal and
Vpr(73—96)—bgal proteins in vitro under different condi-
tions. First, we investigated the dependence of the import
reactions on protein factors provided by the rabbit reticu-
locyte lysate. Consistent with prior studies, nuclear import
of IBB—bgal was entirely dependent on the addition of the
reticulocyte lysate (Fig. 5 I) (Weis et al., 1996; Grlich et al.,
1996a). In contrast, both Vpr(1—71)—bgal and Vpr(73—96)—
bgal readily entered the nucleus in the presence of buffer
alone (Fig. 5, J and K). Similarly, the full-length Vpr—bgal
protein entered the nucleus in a lysate-independent man-
ner (Fig. 5 L). These results indicate that no rate-limiting
factors required for import of either Vpr targeting signal
are lost during the digitonin permeabilization procedure.
These studies did not exclude the possibility that the nu-
clear localization observed with Vpr(1—71)—bgal, Vpr(73—
96)—bgal, and full-length Vpr—bgal in Fig. 5, J—L, could re-
flect a process of Òfacilitated diffusionÓ rather than actual
nuclear accumulation of Vpr as a result of vectorial im-
port. Entry based on purely facilitated diffusion would be
expected to yield a localization pattern consistent with
equilibration of the protein between the nuclear and cyto-
plasmic compartments. The distinction between a facili-
tated diffusion mechanism and actual nuclear accumula-
tion cannot be made from the previous experiment
performed in buffer; nuclear fluorescence would be ob-
served in both cases because extensive washing of the cells
removes the background fluorescence. To distinguish be-
tween these two possibilities, we measured the nuclear up-
take of FITC-labeled proteins in buffer 30 min into the im-
port reaction in the absence of washing or fixation. Under
these conditions, IBB—bgal is excluded from the nucleus
(Fig. 5 M). In contrast, Vpr(1—71), Vpr(73—96), and the
full-length Vpr protein fused to bgal undergo substantial
nuclear accumulation against a concentration gradient
Figure 5. The two nuclear targeting signals of Vpr exhibit similar biological properties. (A—H) Nuclear import of IBB—bgal, Vpr(1—71)—
bgal, Vpr(73—96)—bgal, and full-length Vpr—bgal in the presence of lysate (control) (A, C, E, and G) or with lysate containing 6 mM of
the RanQ69L mutant, which is unable to hydrolyze bound GTP (B, D, F, and H). (I—L) Nuclear import of IBB—bgal (I), Vpr(1—71)—bgal
(J), Vpr(73—96)—bgal (K), and Vpr—bgal (L) in the absence of added lysate. (M—P) Nuclear uptake of fluorescently labeled proteins
IBB—bgal (M), Vpr(1—71)—bgal (N), Vpr(73—96)—bgal (O), and Vpr—bgal (P) from a buffered solution 30 min into the import reaction.
In this study, cells were visualized without prior washing to evaluate the extent of nuclear accumulation. Images were photographed on
a Leitz diaplan fluorescence microscope illuminated by a mercury arc lamp. (Q—X) Import of IBB—bgal, Vpr(1—71)—bgal, Vpr(73—96)—
bgal, and Vpr—bgal in the presence of lysate (control) (Q, S, U, and W) or lysate containing apyrase (2.5 U/ml) (R, T, V, and X) to de-
plete high-energy phosphates in the lysates. Lysates were preincubated with apyrase for 20 min at room temperature before their use in
the nuclear import assays.
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even in the absence of an energy-regenerating system (Fig.
5, N—P). Thus, nuclear entry of Vpr does not appear to re-
sult from facilitated diffusion but rather reflects a vectorial
transport of the protein into the nucleus.
To examine the energy requirement for nuclear import
mediated by the two Vpr signals, each of the transport re-
actions was incubated with apyrase to deplete the nucle-
otide triphosphate pool. As expected, apyrase treatment
of the lysate effectively eliminated IBB—bgal import (Fig.
5, Q vs. R). In contrast, import of Vpr(1—71)—bgal (Fig. 5,
S vs. T), Vpr(73—96)—bgal (Fig. 5, U vs. V), or full-length
Vpr—bgal (Fig. 5, W vs. X) was not significantly affected by
apyrase-induced energy depletion. Comparable results
were obtained when hexokinase/glucose instead of apy-
rase was used to deplete the energy present in the lysates
(data not shown). Together, these findings suggest that
Vpr(1—71), Vpr(73—96), and full-length Vpr are capable of
mediating nuclear import in the presence of minimal en-
ergy.
Vpr(1—71) and Vpr(73—96) Target Vpr to Two Distinct 
Import Pathways
To further examine receptor specificity in the two Vpr
pathways, cross-competition experiments using the Vpr
fragments were performed. Addition of a 300-fold molar
excess of an unlabeled Vpr(1—71) protein fragment inhib-
ited Vpr(1—71)—bgal nuclear import (Fig. 6, A vs. B). How-
ever, addition of an equimolar amount of Vpr(1—71) did
not prevent nuclear entry mediated by Vpr(73—96) (Fig. 6,
C vs. D) or full-length Vpr (Fig. 6, E vs. F). These findings
demonstrate that nuclear import occurring via the Vpr
(1—71) fragment is a saturable process mediated through a
receptor distinct from that involved in Vpr(73—96) import.
Additionally, the ability of Vpr—bgal to enter the nucleus
in the presence of an excess of the Vpr(1—71) protein frag-
ment indicates that the COOH-terminal signal is func-
tional in the context of the full-length protein.
These competition experiments were next extended to
the COOH-terminal signal of Vpr using synthetic peptides
corresponding to amino acids 73—96 synthesized in the for-
ward or reverse orientation. The Vpr(73—96) peptide ef-
fectively inhibited nuclear localization of Vpr(73—96)—bgal
(Fig. 6 J). In contrast, nuclear import of Vpr(73—96)—bgal
was not inhibited by the control reverse peptide (Fig. 6 I).
These findings demonstrate that transport of the Vpr
COOH-terminal signal also involves a saturable receptor.
Addition of the Vpr(73—96) peptide also blocked nuclear
import of both Vpr(1—71)—bgal (Fig. 6, G vs. H) and full-
length Vpr—bgal (Fig. 6, K vs. L). These results suggest
that the two signals bind to two factors that may partici-
pate sequentially in a common nuclear import pathway
with Vpr(73—96) interacting with a receptor positioned
downstream of the receptor recognized by Vpr(1—71).
Vpr(1—71) and Vpr(73—96) Use Distal Components of 
the NLS and M9 Nuclear Import Pathways
We next analyzed the effects of the Vpr fragments on nu-
clear import mediated through the NLS and M9 pathways.
Although saturation of either the NLS or the M9 pathway
failed to block import mediated by Vpr(1—71) or Vpr(73—
96) (Fig. 4), addition of an excess of either Vpr(1—71) or
Vpr(73—96) fragments markedly inhibited import medi-
ated by either the classical NLS (Fig. 7, A vs. B) or the M9
(Fig. 7, C vs. D) signal. Together, these experiments sug-
gest that Vpr(1—71) associates with the NPC either at the
site where the NLS and the M9 pathways converge or
downstream of this junction. Vpr(73—96) also enters this
pathway but even further downstream of the site of
Figure 6. The two nuclear
targeting signals of Vpr tar-
get the protein to distinct
import pathways. (A—F)
Import of Vpr(1—71)—bgal,
Vpr(73—96)—bgal, and full-
length Vpr—bgal with lysate
(control) (A, C, and E) or
with lysate containing 50 mM
unlabeled Vpr(1—71) as a
competitor (B, D, and F).
(G—L) Import of Vpr(1—71)—
bgal, Vpr(73—96)—bgal, and
Vpr—bgal with lysate contain-
ing unlabeled Vpr(96—73) re-
verse peptide as a control (G,
I, and K) or Vpr(73—96) for-
ward peptide (H, J, and L).
Peptides were used at a final
concentration of 500 mM.
The Journal of Cell Biology, Volume 143, 1998 882
Vpr(1—71) engagement, thus accounting for the ability of
Vpr(73—96) to block import mediated by the Vpr(1—71),
NLS, and M9 signals.
Discussion
Nuclear Entry of Vpr Is Signal-mediated, Occurs via the 
NPC, and Is Not the Result of Facilitated Diffusion
In this study, we show that nuclear localization of Vpr is a
signal-mediated process. Specifically, Vpr efficiently tar-
gets an appended protein to the nucleus, even when the fu-
sion partner is a normally cytoplasmic protein larger than
the 40—60-kD size limit for passive diffusion. This ob-
served property is consistent with the proposed role of
Vpr in mediating nuclear uptake of the large viral PIC.
Vpr-mediated transport into the nucleus appears to occur
through the NPC since this process is inhibited by the ad-
dition of both WGA and a dominant-negative mutant of
importin b, importin b (71—876), which blocks multiple in-
dependent import and export pathways (Kutay et al.,
1997b). In contrast to a recent report suggesting that Vpr
targets proteins to the nuclear envelope (Vodicka et al.,
1998), we observe Vpr-mediated targeting to the nucleo-
plasm. Of note, transient transfection of cells with an untagged
Vpr expression vector similarly leads to a nucleoplasm
pattern of localization detected by immunofluorescence
staining with anti-Vpr antibody (data not shown). We sus-
pect that the use of different alleles of Vpr and/or slight
conformational variations between the experimental Vpr
fusion proteins may contribute to these different results.
In a separate study (Fouchier et al., 1998), a protein chi-
mera composed of Vpr fused to maltose binding protein
was reported to localize to the nucleus while a Vpr—bgal
chimera was detected both in the nucleus and at the nu-
clear envelope. For the Vpr—bgal protein chimera used in
this study, we find nucleoplasmic localization both for the
expressed protein in transiently transfected HeLa cells
and for the recombinant protein in digitonin-permeabi-
lized HeLa cells. These results indicate that Vpr is capable
of targeting proteins to the nucleus.
Our studies further demonstrate that Vpr contains two
functional nuclear targeting signals that reside within the
1—71 and 73—96 fragments and can efficiently direct this
HIV protein to the nucleoplasm. Of note, these two re-
gions of Vpr correlate well with regions observed after
limited proteolysis, suggesting that they may correspond
to structural domains within the protein (Zhao et al.,
1994). In contrast to previous studies suggesting a promi-
nent role for the NH2 terminus of Vpr in nuclear targeting
(Di Marzio et al., 1995; Mahalingam et al., 1995; Yao et al.,
1995), we find that the COOH-terminal signal is also capa-
ble of mediating nuclear localization, both alone and in the
context of the full-length protein. The ability of Vpr to ac-
cess the nucleus using two different signals should be
taken into consideration when attempting to identify indi-
vidual amino acid residues critical for such targeting.
A feature of Vpr-mediated nuclear import that sharply
contrasts with import mediated through the classical NLS-
or M9-dependent pathway is the ability of Vpr to enter the
nucleus efficiently under conditions of minimal energy.
This property of Vpr is conferred by both of its nuclear
targeting signals. Specifically, we show that Vpr-mediated
nuclear entry occurs in the absence of exogenously added
energy and even persists in energy-depleted lysates. De-
spite such conditions of limited energy, nuclear localiza-
tion of Vpr results from net accumulation, rather than sim-
ple equilibration through facilitated diffusion.
How is Vpr able to mediate nuclear enrichment in the
presence of minimal energy levels? The decreased energy
requirement for entry may be a function of the discrete
sites along the NPC where Vpr(1—71) and Vpr(73—96)
bind. Based on several lines of evidence, both Vpr target-
ing signals appear to engage the NPC at positions located
downstream of the sites of association of the NLS- and
M9-transport complexes (see below). Alternatively, the
absolute energy requirement for Vpr-mediated nuclear
import may simply be much lower than that observed for
import via the classical NLS pathway. Finally, digitonin
permeabilization may not completely release energy
stores associated with the NPC, explaining the ability of
Vpr to enter the nucleus in the absence of exogenously
Figure 7. Vpr(1—71) and
Vpr(73—96) block nuclear im-
port mediated through both
the classical NLS and M9
pathways. (A—D) Import of
IBB—bgal and GST-M9 in the
presence of lysate (control)
(A and C) or with lysate con-
taining 50 mM Vpr(1—71) (B
and D). (E—H) Import of
IBB—bgal and GST-M9 with
lysate containing Vpr(96—73)
reverse peptide (control) (E
and G) or containing
Vpr(73—96) forward peptide
(F and H). Peptides were
used at a final concentration
of 500 mM.
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added nucleotide triphosphates. The fact that Vpr-medi-
ated translocation does not occur at 08C suggests that
some energy is required. However, we cannot exclude a
temperature-dependent conformational change in the
NPC that inhibits signal-mediated transport. Future exper-
iments will attempt to distinguish between these various
possibilities. Further study of Vpr import also promises to
yield new insights into the mechanism by which proteins
translocate from one face of the NPC to the other. The
ability of Vpr to localize to the nucleus in the absence of
exogenously added protein factors and energy provides a
simplified model system that should facilitate the elucida-
tion of the precise mechanics of the transport reaction. Fi-
nally, the presence of nuclear targeting signals that oper-
ate effectively under conditions of limited energy may
enhance viral replication and spread in nondividing cells
by facilitating nuclear uptake of the viral PIC through in-
creasing its import kinetics.
Vpr Uses an Import Pathway Distinct from NLS or M9 
and Does Not Require GTP Hydrolysis by Ran/TC4
Unlike nuclear import occurring through the classical NLS
and M9 signals, nuclear entry of Vpr—bgal does not appear
to require GTP hydrolysis mediated by Ran/TC4. Specifi-
cally, both the Vpr(1—71)—bgal and Vpr(73—96)—bgal fu-
sion proteins are entirely resistant to the inhibitory effects
of the RanQ69L mutant, which fails to undergo GTP hy-
drolysis.
Consistent with the Ran independence of transport,
blockade of either the Ran-dependent NLS or the M9
pathways using either an excess of unlabeled IBB- or M9-
containing protein competitors produced no inhibitory ef-
fects on nuclear import mediated by full-length Vpr or ei-
ther of the Vpr fragments. These findings confirm that Vpr
does not use importin a/importin b— or transportin-medi-
ated pathways for nuclear entry. Binding of Vpr to both
yeast and human importin a has been reported (Popov et al.,
1998; Vodicka et al., 1998). However, the ability of Vpr to
efficiently enter the nucleus in the presence of an excess of
the IBB competitor clearly demonstrates that importin a
function is not required for import of Vpr itself.
In terms of other receptors possibly used by Vpr, we
have not formally eliminated the human homologue of
Kap123p, a recently described yeast transporter of riboso-
mal proteins (Rout et al., 1997). However, Vpr utilization
of this pathway seems unlikely since Kap123p, like impor-
tin b and transportin, contains a RanGTP binding domain
and has been shown to bind RanGTP in vitro (Schlenstedt
et al., 1997), suggesting a role for Ran in transport of
Kap123p. As noted above, Vpr import is unaffected by
the presence of a dominant-negative mutant of Ran,
RanQ69L, suggesting that Vpr does not use Kap123p or,
by analogy, other members of this superfamily of RanGTP
binding proteins.
The Two Nuclear Targeting Signals in Vpr Are 
Unique and Bind to Receptors Shared by the Classical 
NLS and M9 Import Pathways
An unusual feature of Vpr is that this small, 96—amino acid
protein of HIV contains two distinct nuclear targeting sig-
nals that use different receptors. Characterization of the
two Vpr nuclear targeting signals reveals that import me-
diated by either signal in vitro occurs independently of
added lysate proteins and, as noted above, under condi-
tions of limited energy. Competition experiments designed
to probe the receptors involved demonstrate that the addi-
tion of an excess of the Vpr(1—71) protein fragment inhib-
its import mediated by Vpr(1—71) but does not alter
import mediated by Vpr(73—96) or the full-length Vpr
protein. In contrast, competition with excess unlabeled
Vpr(73—96) peptide, but not the reverse peptide as a con-
trol, inhibits import of Vpr(1—71)—bgal and Vpr(73—96)—
bgal, as well as full-length Vpr—bgal. These findings sug-
gest a model for nuclear entry of Vpr(73—96) involving a
receptor positioned distally in a convergent import path-
way used by both Vpr signals.
Further support for such a convergent pathway of nu-
clear import was also obtained when the Vpr fragments
were tested for effects on the NLS and M9 import path-
ways. Although the NLS- and M9-specific inhibitors exert
no inhibitory effects on either Vpr nuclear targeting signal,
both the Vpr(1—71) and Vpr(73—96) fragments, when
added as competitors, effectively block the NLS and M9
pathways. These findings argue that the two Vpr frag-
ments act at later points in a nuclear import pathway also
used by NLS- and M9-bearing proteins and their respec-
tive receptors. In this regard, Popov and colleagues (1998)
have also reported that Vpr blocks nuclear import of NLS-
containing substrates. The eventual convergence of dis-
tinct nuclear import pathways at the NPC is also sup-
ported by data from Michael and colleagues (1997), who
have described inhibition of the NLS and M9 pathways by
saturation of the import pathway used by the hnRNP K
nuclear targeting signal, and by data from Kutay and co-
workers (1997b), showing inhibition of multiple import
and export pathways by importin b (71—876).
What is the nature of these Vpr receptors? As noted,
both the NH2- and the COOH-terminal signals of Vpr me-
diate nuclear entry in the absence of added soluble factors,
indicating either that the import receptors are not released
from the NPC upon digitonin permeabilization or that
both Vpr(1—71) and Vpr(73—96) directly associate with
components of the NPC. In this regard, binding of full-
length Vpr to the yeast nucleoporin Nsp1p (Vodicka et al.,
1998) and to the vertebrate nucleoporin POM 121 (Fouch-
ier et al., 1998) has recently been described. In addition,
although Vpr-mediated nuclear import is unaffected by
the IBB domain of importin a, inclusion of full-length im-
portin b inhibits nuclear localization of Vpr—bgal (data not
shown), suggesting that Vpr and importin b may use com-
mon intermediates to enter the nucleus. The Vpr(1—71)
and Vpr(73—96) fragments will certainly serve as valuable
reagents to probe the identity of these two different recep-
tors. It is also possible that the two Vpr nuclear targeting
signals interact with different sites on the same protein.
Such a model could also explain the observed nonrecipro-
cal pattern of inhibition observed for Vpr(73—96) and
Vpr(1—71) binding.
Implications for Nuclear Targeting of the HIV 
Preintegration Complex
It has been proposed that Vpr acts as a specialized impor-
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tin b for the delivery of the HIV preintegration complex to
the nuclear envelope (Vodicka et al., 1998). Vpr has been
shown to bind to importin a and the FG repeat—containing
nucleoporins Nsp1p and POM 121. Similarly, importin b
has also been shown to bind directly to FG repeat—con-
taining nucleoporins in vitro (Radu et al., 1995b; Rexach
and Blobel, 1995). Overexpression of Vpr in yeast resulted
in an mRNA export defect, but surprisingly, no import de-
fect was observed (Vodicka et al., 1998).
Our data suggest that Vpr contains minimal elements
required for transport, allowing for passage through the
NPC. As with importin b, transportin, and exportin-t
(Kose et al., 1997; Nakielny and Dreyfuss, 1997; Kutay et
al., 1998), nuclear import of Vpr does not require soluble
factors. As observed with importin b (71—876), addition of
either the NH2- or COOH-terminal nuclear targeting signal
of Vpr blocks import of both NLS- and M9-bearing import
substrates. Based on experiments performed in vitro,
Bukrinsky and coworkers have proposed that Vpr functions
by enhancing the association of the classical NLS found in
the matrix protein with importin a, thereby making a weak
karyophile into a stronger karyophile (Popov et al., 1998).
Our results clearly show that Vpr entry into the nucleus
occurs independently of importin a function and also dem-
onstrate that Vpr itself is highly karyophilic and is able to
mediate nuclear localization on its own through two path-
ways distinct from the classical NLS pathway.
Although we have identified two import pathways dif-
ferent from the classical NLS pathway that are potentially
accessed by the viral PIC, how this assembly localizes to
the nucleus is still unknown. Matrix and integrase are be-
lieved to target this viral complex to the nucleus via the
classical NLS pathway. Our data suggest that the PIC also
has access, because of Vpr, to two nonredundant import
pathways distinct from that used by classical NLS-contain-
ing proteins. The presence of Vpr may serve to facilitate
nuclear uptake of the PIC, perhaps by influencing the im-
port kinetics due to the accessibility of an NLS that oper-
ates effectively under conditions of minimal energy and/or
by enabling the viral PIC to directly engage the NPC. De-
spite these uncertainties, these findings highlight the evo-
lution of HIV to encode a viral factor that bypasses many
of the critical proximal components that govern other nu-
clear import pathways. Rather, Vpr appears to bind to re-
ceptors located within the NPC, a property that may help
to ensure the capacity of HIV to replicate in nondividing
cellular hosts.
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